Deep search
Search
Copilot
Images
Videos
Maps
News
Shopping
More
Flights
Travel
Hotels
Real Estate
Notebook
Top stories
Sports
U.S.
2024 Election
Local
World
Science
Technology
Entertainment
Business
More
Politics
Any time
Past hour
Past 24 hours
Past 7 days
Past 30 days
Best match
Most recent
Alzheimer's, Donanemab
Eli Lilly Alzheimer's Drug Faces Tough Road In UK, Price Watchdog NICE Says Donanemab Is Not Cost-Effective
On Wednesday, U.K. regulators approved Eli Lilly And Co’s (NYSE:LLY) donanemab, an injection for intravenous infusion to treat mild cognitive impairment and mild dementia due to Alzheimer’s disease. The infusion,
U.K.’s cost-effectiveness agency says Alzheimer’s drug donanemab does not provide good value
For the second time in recent months, a U.K. agency said the limited benefits of a new Alzheimer’s drug do not justify its costs.
Second Alzheimer’s drug, donanemab, rejected for NHS use
The UK Medicines and Healthcare products Regulatory Agency (MHRA) has approved US pharma major Eli Lilly’s Kisunla (donanemab) for people in Britain with mild cognitive impairment or those in the early stages of Alzheimer’s disease.
12h
on MSN
Donanemab – what we know about the latest Alzheimer’s drug
Donanemab can slow the progression of Alzheimer’s disease.But what is the drug and how does it work? Here your questions on ...
10h
on MSN
UK approves Lilly's Alzheimer's drug, but deemed 'too expensive' for wide use
UK's Medicines and Healthcare products Regulatory Agency (MHRA) approved Eli Lilly's treatment for early Alzheimer's, the ...
Outsourcing-pharma
5h
NICE rejects Donanemab for NHS use despite MHRA approval
Donanemab marks a significant advancement in Alzheimer’s treatment, but NHS patients face a setback with NICE's rejection of ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Trending now
Settles civil lawsuit
NK troops in RU confirmed
Linked to E. coli outbreak
Joins Republican Party
Yelp disables reviews
Trespassing charge upheld
No abortion concessions
Arlington visit records order
Veteran film producer dies
Sues Biden administration
Dodgers legend dies
To close 150 locations
2 US troops injured in raid
Giant ‘ghost’ fish spotted
DOJ alleges racial bias
Lake Erie toxic algae study
MO court upholds release
Hashem Safieddine killed
FDA approves RSV vaccine
First father-son duo in NBA
GA election rules appeal
Sex crimes trial next year
Gun assault trial delayed
US fines American Airlines
Israel strikes Lebanese city
G7 Ukraine loan advances
Bird flu infects 4 in WA
Feedback